Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Vis graf over relationer

Primære forskningsområder



Ulrik Pedersen-Bjergaard



Personal data

  • Medical doctor 1986, certified specialist in general internal medicine 1996 and endocrinology 2006
  • Consultant 2007-2009, -
  • Chief of endocrinology 2009-2012, -
  • Consultant and Senior Research Fellow, from 2012, - Endocrinology Section, Department of Cardiology, Nephrology and Endocrinology H, Nordsjællands Hospital Hillerød
  • Associate professor, PhD Administration, Faculty of Health Sciences, University of Copenhagen, from 2009


Scientific qualifications
  • Doctor of Medical Science (DMSc), University of Copenhagen, 2009


Scientific publications and presentations

  • 68 scientific papers, 4 scientific letters, 9 reviews
  • 107 abstracts, 57 oral presentations, 60 posters
  • 1 patent application
  • Citations: 979; H-index: 18


Miscellaneous scientific qualifications
  • Principal mentor at 3 PhD projects and mentor at 5 PhD projects (2 ongoing)
  • Opponent at 2 PhD theses
  • Reviewer of 23 scientific papers for 17 international scientific journals since 2004
  • Investigator/co-investigator in 14 international multi-centre RCT studies since 2007
  • Fund raising as principal applicant and as member of the Hypoglycaemia Research Group: 1998 – : 21,147,000 DKK


Teaching qualifications

  • Since 1998 numerous oral educational presentations about endocrinology, particularly diabetes, for medical doctors, other health care professionals, patients and relatives
  • Teacher at 1 postgraduate specialist course in endocrinology (topic: “hypoglycaemia”) 2005
  • Organiser and teacher at 2 local educational endocrinology meetings for healthcare professionals 2010
  • Invited speaker and teacher at 3 international courses in diabetology in China since 2003
  • Teacher at 2 PhD courses in ”Methods and Techniques in Diabetes Research” since 2005
  • Pregraduate teaching of medical students since 2007



  • Member of Danish Society for Internal Medicine (DSIM), Danish Endocrine Society (DES), and European Association for the Study of Diabetes (EASD)
  • Participation in more than 20 international congresses, scientific meetings etc. since 1998


Postdoctoral thesis (DMSc)


Severe hypoglycaemia in type 1 diabetes: Impact of the renin-angiotensin system and other risk factors. Dan Med Bull 56:193-207;2009.


Faculty of Health Sciences, University of Copenhagen, public defence September 25th, 2009.


List of 10 selected papers


1.           Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B.

              Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus.

              Lancet 357:1248-1253;2001.


2.           Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B.

              Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes.

              Diabetologia 46:89-96;2003.


3.           Jørgensen HV, Pedersen-Bjergaard URasmussen ÅK, Borch-Johnsen K.

              The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives to patients with type 1 diabetes.

              Diabetes Care 26:1106-1109;2003.


4.           Pedersen-Bjergaard U, Pramming S, Heller S, Wallace TM, Rasmussen ÅK, Jørgensen HV, Matthews DR, Hougaard P, Thorsteinsson B.

              Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection.

              Diabet Metab Res Rev 20:479-486;2004.


5.           Pedersen-Bjergaard U, Reubsaet JLE, Nielsen SL, Pedersen-Bjergaard S, Perrild H, Pramming S, Thorsteinsson B.

Psychoactive drugs, alcohol, and severe hypoglycemia in insulin-treated diabetes: Analysis of 141 cases.

              Am J Med 118:307-310;2005.


  1. Pedersen-Bjergaard U, Dhamrait SS, Sethi AA, Frandsen E, Nordestgaard BG, Montgomery H, Pramming S, Hougaard P, Thorsteinsson B.

Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.Am J Med 121:246e1-246e8;2008.


  1. Bie-Olsen, LG, Pedersen-Bjergaard U, Kjær TW, Lonsdale MN, Law I, Thorsteinsson B. Association between regional cerebral blood flow during hypoglycemia and genetic and phenotypic traits of the renin-angiotensin system.

              J Cerebr Blood F Met 29:1790-1795;2009.


8.           Kristensen PL, Pedersen-Bjergaard USchalkwijk C, Olsen NV, Thorsteinsson B. Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes.

Eur J Endocrinol 163:391-398;2010.


9.           Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Boomsma F, Damm P, Mathiesen ER. A high level of prorenin in early pregnancy is associated with development of preeclampsia in women with type 1 diabetes.

Diabetologia 54:1615-1619;2011.


10.         Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Hougaard P, Parving H-H, Thorsteinsson B, Tarnow L. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-labelled, blinded-endpoint crossover trial.

              Lancet Diab Endocrinol 2:553-561; 2014.

ID: 39952